A 66-year-old cisgender woman with HIV has been taking bictegravir-tenofovir alafenamide-emtricitabine and has consistent suppression of HIV RNA levels. She has a CD4 count of 186 cells/mm3. Recently, she was admitted to the hospital with a myocardial infarction. She has a 40-pack-year smoking history, a body mass index (BMI) of 35, and type 2 diabetes mellitus.
Which one of the following is TRUE regarding the risk for myocardial infarction in persons with HIV?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 26th, 2023
September 26th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5